Ronald Tong

Researchers sought to compare the incidence of and risk factors for new-onset persistent HTN after COVID-19 vs influenza infection .

An eye-tracking test has identified a potential performance-based biomarker for the early diagnosis of autism spectrum disorder (ASD).

Researchers conducted a phase 2 trial to assess the safety and efficacy of single-dose psilocybin treatment for major depressive disorder.

In a phase 3 clinical trial, researchers are assessing the safety and efficacy of fosgonimeton with a randomized treatment duration of 26 weeks for mild to moderate Alzheimer disease.